Gene · 90
Papers2,859
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,281 to 1,300 of 2,859
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Urine-Derived Stem Cells: Applications in Regenerative and Predictive Medicine. | Cells | 2020 | 32121221 | PubTator, text mining | PubMed |
| Invaders Exposed: Understanding and Targeting Tumor Cell Invasion in Diffuse Intrinsic Pontine Glioma. | Front Oncol | 2020 | 32117746 | PubTator, text mining | PubMed |
| Oncogenic Role of PVT1 and Therapeutic Implications. | Front Oncol | 2020 | 32117705 | PubTator, text mining | PubMed |
| ALK2: A Therapeutic Target for Fibrodysplasia Ossificans Progressiva and Diffuse Intrinsic Pontine Glioma. | Chem Pharm Bull (Tokyo) | 2020 | 32115526 | PubTator, text mining | PubMed |
| Proteolysis and cartilage development are activated in the synovium after surgical induction of post traumatic osteoarthritis. | PLoS One | 2020 | 32107493 | PubTator, text mining | PubMed |
| Bone Morphogenetic Protein 4 Targeting Glioma Stem-Like Cells for Malignant Glioma Treatment: Latest Advances and Implications for Clinical Application. | Cancers (Basel) | 2020 | 32102285 | PubTator, text mining | PubMed |
| Emerging roles of the αC-β4 loop in protein kinase structure, function, evolution, and disease. | IUBMB Life | 2020 | 32101380 | PubTator, text mining | PubMed |
| Network-Based Genetic Profiling Reveals Cellular Pathway Differences Between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma. | Int J Environ Res Public Health | 2020 | 32093341 | PubTator, text mining | PubMed |
| Transcriptome Analysis Identifies ALCAM Overexpression as a Prognosis Biomarker in Laryngeal Squamous Cell Carcinoma. | Cancers (Basel) | 2020 | 32085563 | PubTator, text mining | PubMed |
| Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study. | Cancers (Basel) | 2020 | 32085544 | PubTator, text mining | PubMed |
| Role of Signal Transduction Pathways and Transcription Factors in Cartilage and Joint Diseases. | Int J Mol Sci | 2020 | 32079226 | PubTator, text mining | PubMed |
| Comprehensive Proteomic Characterization Reveals Subclass-Specific Molecular Aberrations within Triple-negative Breast Cancer. | iScience | 2020 | 32058975 | PubTator, text mining | PubMed |
| Fibrodysplasia ossificans progressiva as a form of pseudodystonia. | Parkinsonism Relat Disord | 2020 | 32046912 | PubTator, text mining | PubMed |
| The hypoxic microenvironment: a driving force for heterotopic ossification progression. | Cell Commun Signal | 2020 | 32028956 | PubTator, text mining | PubMed |
| Regulation of mesenchymal stem cell differentiation on microstructured titanium surfaces by semaphorin 3A. | Bone | 2020 | 32028017 | PubTator, text mining | PubMed |
| Isolation and characterization of immune cells from the tumor microenvironment of genetically engineered pediatric high-grade glioma models using the sleeping beauty transposon system. | Methods Enzymol | 2020 | 32000905 | PubTator, text mining | PubMed |
| Deregulated bone morphogenetic proteins and their receptors are associated with disease progression of gastric cancer. | Comput Struct Biotechnol J | 2020 | 31988704 | PubTator, text mining | PubMed |
| A Multi-Omics Analysis of Bone Morphogenetic Protein 5 (BMP5) mRNA Expression and Clinical Prognostic Outcomes in Different Cancers Using Bioinformatics Approaches. | Biomedicines | 2020 | 31973134 | PubTator, text mining | PubMed |
| Dissecting Molecular Features of Gliomas: Genetic Loci and Validated Biomarkers. | Int J Mol Sci | 2020 | 31968687 | PubTator, text mining | PubMed |
| Fibrin(ogen) in human disease: both friend and foe. | Haematologica | 2020 | 31949010 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/90/papers?page=65